Fortis Healthcare Ltd
NSE:FORTIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fortis Healthcare Ltd
NSE:FORTIS
|
IN |
|
Rentokil Initial PLC
LSE:RTO
|
UK |
|
I
|
Internet Initiative Japan Inc
OTC:IIJIY
|
JP |
|
E
|
Evolution AB (publ)
F:E3G1
|
SE |
|
Burcon NutraScience Corp
F:BNE0
|
CA |
|
E
|
Exxon Mobil Corp
XBER:XONA
|
US |
Fortis Healthcare Ltd
Fortis Healthcare Ltd is a hospital and healthcare services company in India. It owns and runs hospitals, clinics, and diagnostics facilities that treat patients for everything from routine care to complex surgery and critical care. The company earns money mainly from patient fees, health insurance reimbursements, and payments from other healthcare providers that use its facilities. Its main customers are patients, families, insurers, and doctors who refer people for specialist treatment. Fortis also sells diagnostic and support services such as imaging, lab tests, and pharmacy products through its medical network. In simple terms, it sits in the middle of the healthcare chain: it provides the place, staff, and equipment needed to deliver care. What makes the business model distinct is that it is built around physical medical infrastructure and clinical expertise, not just software or distribution. Fortis depends on trusted hospital brands, specialist doctors, and the ability to handle advanced treatments that smaller clinics cannot offer. That gives it a role as a premium healthcare provider for patients who need organized, multi-specialty care.
Fortis Healthcare Ltd is a hospital and healthcare services company in India. It owns and runs hospitals, clinics, and diagnostics facilities that treat patients for everything from routine care to complex surgery and critical care. The company earns money mainly from patient fees, health insurance reimbursements, and payments from other healthcare providers that use its facilities.
Its main customers are patients, families, insurers, and doctors who refer people for specialist treatment. Fortis also sells diagnostic and support services such as imaging, lab tests, and pharmacy products through its medical network. In simple terms, it sits in the middle of the healthcare chain: it provides the place, staff, and equipment needed to deliver care.
What makes the business model distinct is that it is built around physical medical infrastructure and clinical expertise, not just software or distribution. Fortis depends on trusted hospital brands, specialist doctors, and the ability to handle advanced treatments that smaller clinics cannot offer. That gives it a role as a premium healthcare provider for patients who need organized, multi-specialty care.
Strong Revenue Growth: Fortis Healthcare reported Q3 consolidated revenue of INR 2,265 crores, up 17.5% year-on-year. Hospital revenue grew 19.4%, while diagnostics grew 7.3%.
Margin Expansion: Operating EBITDA for Q3 rose 34.8% to INR 505 crores, with margins improving from 19.4% to 22.3%. Hospital EBITDA margin rose to 21.7%.
Bed Additions & Acquisitions: 750 beds were added in the first 9 months, with significant contributions from acquisitions and brownfield expansions. The People Tree Hospital in Bengaluru was acquired and will be expanded.
Diagnostics Outperformance: Agilus Diagnostics reported 8.3% revenue growth and significant margin improvement, with operating EBITDA margin at 23.1% versus 14.4% last year.
Profit Impacted by One-Offs: Reported PAT declined to INR 197 crores (from INR 250 crores) due to a one-off labor code expense, despite profit before tax increasing 21.9%.
Digital Revenue Growth: Digital channels now contribute about 30% of hospital revenues, growing 19% year-on-year.
Expansion Pipeline & CapEx: Further brownfield expansion and M&A are in the pipeline, with focus on cluster markets. FMRI and other key facilities are major contributors to upcoming growth.
Balance Sheet & Funding: Net debt stands at INR 2,547 crores; equity infusion from IHH is expected in the next 3–6 months to support future growth.
